Home
Projects
Posts
Publications
Our Team
Job Opportunities
Contact
mortality
Melanoma prognostic model using tissue microarrays and genetic algorithms.
PURPOSE: As a result of the questionable risk-to-benefit ratio of adjuvant therapies, stage II melanoma is currently managed by observation because available clinicopathologic parameters cannot identify the 20% to 60% of such patients likely to …
Cite
×